Related Experiment Videos
Hydromorphone for acute and chronic pain
1Medical Oncology, Hammersmith Hospitals Trust, Du Cane Road, London, UK, W12 0NN. cquigley@hhnt.org
The Cochrane Database of Systematic Reviews
|March 1, 2002
Summary
Hydromorphone is a potent analgesic for managing pain, with efficacy and side effects similar to morphine. However, more research is needed to confirm equi-analgesic ratios and precise differences between these opioids.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Research
Background:
- Morphine is a standard for severe cancer pain but has limitations.
- Hydromorphone is an alternative opioid analgesic.
- Understanding hydromorphone's efficacy and potency requires further investigation.
Purpose of the Study:
- To review and assess the evidence for hydromorphone's efficacy in pain management.
- To explore the comparative effectiveness of hydromorphone against other analgesics.
Main Methods:
- Systematic review of randomized trials involving hydromorphone.
- Searched electronic databases and handsearched journals up to February 2000.
- Included studies on acute and chronic pain in adults and children, assessing validity and blinding.
Main Results:
- 43 studies (2725 subjects) were included; many were of low quality.
- Heterogeneity precluded meta-analysis; few studies were placebo-controlled.
- Hydromorphone appears potent, with efficacy and adverse effects similar to morphine, but small study sizes limit definitive conclusions on equi-analgesic ratios.
Conclusions:
- Despite methodological variations, studies indicate hydromorphone is a potent analgesic.
- Clinical effects of hydromorphone are dose-dependent.
- Adverse effect profiles are comparable to other mu-opioid receptor agonists.